Literature DB >> 6034391

Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.

B Blackwell, E Marley, J Price, D Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6034391     DOI: 10.1192/bjp.113.497.349

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  44 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Authors:  L I Golbe; J W Langston; I Shoulson
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  R-deprenyl: pharmacological spectrum of its activity.

Authors:  K Magyar; B Szende; V Jenei; T Tábi; M Pálfi; E Szöko
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

4.  The role of monoamine oxidase inhibitors in current psychiatric practice.

Authors:  Jess G Fiedorowicz; Karen L Swartz
Journal:  J Psychiatr Pract       Date:  2004-07       Impact factor: 1.325

5.  The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Authors:  Lois Jessen; Lawrence J Kovalick; Albert J Azzaro
Journal:  P T       Date:  2008-04

6.  A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.

Authors:  Melissa P DelBello; Thomas J Hochadel; Kimberly Blanchard Portland; Albert J Azzaro; Alain Katic; Arif Khan; Graham Emslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-06-23       Impact factor: 2.576

Review 7.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

8.  Tyramine content of preserved and fermented foods or condiments of Far Eastern cuisine.

Authors:  M Da Prada; G Zürcher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  The role of rasagiline in the treatment of Parkinson's disease.

Authors:  Julie Leegwater-Kim; Elena Bortan
Journal:  Clin Interv Aging       Date:  2010-05-25       Impact factor: 4.458

10.  Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.

Authors:  A Korn; B Wagner; E Moritz; J Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.